ReviewNature reviews. Gastroenterology & hepatology2019
Too many people with viral hepatitis are diagnosed late - with dire consequences.
Review in Nature reviews. Gastroenterology & hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 36 citations in OpenAlex.
- Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology.JHEP reports : innovation in hepatology · 2025Review
- Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis.The European journal of health economics : HEPAC : health economics in prevention and care · 2024Article
- Kairos in diagnostics.Theoretical medicine and bioethics · 2024Article
- Development and investigation of metabolism-associated risk assessment models for patients with viral hepatitis.Frontiers in cellular and infection microbiology · 2023Article
- Clinical Profile and Limitations in the Management of HBV Patients Attending Clinic at a District Hospital in Ghana.International journal of hepatology · 2023Article
- Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases.EClinicalMedicine · 2022Article
- A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid.Communications medicine · 2022Article
- The Negative Impact of COVID-19 in HCV, HIV, and HPV Surveillance Programs During the Different Pandemic Waves.Frontiers in public health · 2022Article
- Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review.Scientific reports · 2021Article
- Article
- A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in Spain.Scientific reports · 2021Article
- Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohort.AIDS research and therapy · 2021Observational
- Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020Article
- [Progress, challenges and countermeasures of global hepatitis C elimination].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020Article
- Progress towards elimination goals for viral hepatitis.Nature reviews. Gastroenterology & hepatology · 2020Article
- Programmable low-cost DNA-based platform for viral RNA detection.Science advances · 2020Article
- Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination?Journal of clinical microbiology · 2019Article
- Hepatitis C elimination protocol in Cantabria: Updated regional strategy and outcomes from a population-based cohort and opportunistic screening programs.Sage open chronic diseaseArticle
- Alcohol Consumption Impacts Liver Fibrosis Progression in Minority of Patients Screened for Hepatitis C at Drug Treatment Centers.Substance use : research and treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 5 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.